We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current AVXL market cap is 781.15M. The company's latest EPS is USD -0.5037 and P/E is -18.01.
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -12.52M | -14.73M | -14.34M | -13.59M | -12.51M |
| Net Income | -10.55M | -12.21M | -11.62M | -12.11M | -11.2M |
| Year End September 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 54k | 0 | 0 | 0 |
| Operating Income | -31.09M | -41.95M | -50.99M | -55.76M | -52.88M |
| Net Income | -26.28M | -37.91M | -47.98M | -47.51M | -43M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 144.52M | 141.54M | 135.57M | 124.04M | 117.14M |
| Total Liabilities | 9.56M | 11.75M | 15.3M | 13.13M | 17.38M |
| Total Equity | 134.96M | 129.78M | 120.26M | 110.92M | 99.76M |
| Year End September 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 34.54M | 161.62M | 152.71M | 154.39M | 135.57M |
| Total Liabilities | 7.31M | 10.8M | 10.21M | 12.53M | 15.3M |
| Total Equity | 27.24M | 150.82M | 142.49M | 141.85M | 120.26M |
| Quarter End | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -18.97M | -24.15M | -30.81M | -12.12M | -17.98M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 7.34M | 11.89M | 11.98M | 708k | 1.56M |
| Year End September 29 2024 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -21.29M | -30.38M | -24.24M | -27.79M | -30.81M |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 28.35M | 153.24M | 21.29M | 29.65M | 11.98M |
| Market Cap | 781.15M |
| Price to Earnings Ratio | -18.01 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 5.86 |
| Price to Book Ratio | 6.44 |
| Dividend Yield | - |
| Shares Outstanding | 85.37M |
| Average Volume (1 week) | 734.63k |
| Average Volume (1 Month) | 778.08k |
| 52 Week Change | 137.66% |
| 52 Week High | 14.4405 |
| 52 Week Low | 3.76 |
| Spread (Intraday) | 0.65 (7.03%) |
| Company Name | Anavex Life Sciences Corporation |
| Address |
701 s carson st carson city, nevada 89701 |
| Website | https://www.anavex.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
